UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular classification and grading of meningioma

Journal of neuro-oncology, 2023, Vol.161 (2), p.373-381

2023

Volltextzugriff (PDF)

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

Science translational medicine, 2017-07, Vol.9 (399)

2017

Volltextzugriff (PDF)

Neuropathology associated with SARS-CoV-2 infection

The Lancet (British edition), 2021-01, Vol.397 (10271), p.277-277

2021

Volltextzugriff (PDF)

Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1

Scientific reports, 2018-03, Vol.8 (1), p.5087-12, Article 5087

2018

Volltextzugriff (PDF)

Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1

Acta neuropathologica, 2023-01, Vol.145 (1), p.71-82

2023

Volltextzugriff (PDF)

Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma

Scientific reports, 2022-05, Vol.12 (1), p.8784-8784, Article 8784

2022

Volltextzugriff (PDF)

Withdrawn as duplicate: Commentary: "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing

Neurosurgery, 2021-10, Vol.89 (4), p.E237-E238

2021

Volltextzugriff (PDF)

Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss

Modern pathology, 2019-10, Vol.32 (10), p.1434-1446

2019

Volltextzugriff (PDF)

Prognostic stratification of glioblastoma patients by unsupervised clustering of morphology patterns on whole slide images furthering our disease understanding

Frontiers in neuroscience, 2024-05, Vol.18, p.1304191-1304191

2024

Volltextzugriff (PDF)

Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas

Journal of translational medicine, 2023-04, Vol.21 (1), p.287-287, Article 287

2023

Volltextzugriff (PDF)

Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastoma

British journal of cancer, 2019-01, Vol.120 (1), p.54-56

2019

Volltextzugriff (PDF)

Molecular and clinicopathologic features of gliomas harboring NTRK fusions

Acta neuropathologica communications, 2020-07, Vol.8 (1), p.107-14, Article 107

2020

Volltextzugriff (PDF)

Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma

Nature communications, 2022-07, Vol.13 (1), p.3936-3936, Article 3936

2022

Volltextzugriff (PDF)

Clinical Evaluation of IDH Mutation Status in Formalin-Fixed Paraffin-Embedded Tissue in Gliomas

Molecular diagnosis & therapy, 2023-05, Vol.27 (3), p.371-381

2023

Volltextzugriff (PDF)

MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma

Journal of neuro-oncology, 2022-02, Vol.156 (3), p.645-653

2022

Volltextzugriff (PDF)

Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model

Journal of neuro-oncology, 2023-05, Vol.163 (1), p.173-183

2023

Volltextzugriff (PDF)

Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors

Molecular therapy, 2022-07, Vol.30 (7), p.2537-2553

2022

Volltextzugriff (PDF)

Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study

Clinical cancer research, 2020-01, Vol.26 (2), p.397-407

2020

Volltextzugriff (PDF)

The second window ICG technique demonstrates a broad plateau period for near infrared fluorescence tumor contrast in glioblastoma

PloS one, 2017-07, Vol.12 (7), p.e0182034

2017

Volltextzugriff (PDF)

In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature

Neuro-oncology (Charlottesville, Va.), 2018-07, Vol.20 (8), p.1068-1079

2018

Volltextzugriff (PDF)

CTDSP2::GLI1 fusion in glioblastoma: A diagnostic challenge through tumor heterogeneity

Journal of neuropathology and experimental neurology, 2024-07

2024

Volltextzugriff (PDF)

Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine

Cancers, 2021-11, Vol.13 (23), p.5921

2021

Volltextzugriff (PDF)

1 – 25 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(180)

Publikationsform

Sprache

Englisch
(195)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Molecular classification and grading of meningioma

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

Neuropathology associated with SARS-CoV-2 infection

Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1

Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1

Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma

Withdrawn as duplicate: Commentary: "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing

Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss

Prognostic stratification of glioblastoma patients by unsupervised clustering of morphology patterns on whole slide images furthering our disease understanding

Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas

Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastoma

Molecular and clinicopathologic features of gliomas harboring NTRK fusions

Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma

Clinical Evaluation of IDH Mutation Status in Formalin-Fixed Paraffin-Embedded Tissue in Gliomas

Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results

MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma

Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model

Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development

Histopathology‐validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo‐progression in glioblastoma

Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors

Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study

The second window ICG technique demonstrates a broad plateau period for near infrared fluorescence tumor contrast in glioblastoma

In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature

CTDSP2::GLI1 fusion in glioblastoma: A diagnostic challenge through tumor heterogeneity

Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine

Suchergebnisse filtern